4.8 Article

Novel Ce(III)-Metal Organic Framework with a Luminescent Property To Fabricate an Electrochemiluminescence Immunosensor

期刊

ACS APPLIED MATERIALS & INTERFACES
卷 12, 期 1, 页码 338-346

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsami.9b19246

关键词

Ce-based luminescent metal-organic framework; proprotein convertase subtilisin/kexin type 9; electrochemiluminescence; 4,4',4 '',4 '''-(porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid); polyamidoamine dendrimer

资金

  1. National Nature Science Foundation of China [81370403]
  2. Chongqing foundation [CSTC2015jcyjBX0053]
  3. Chongqing precision medical key technology research and development and demonstration projects [cstc2016shms-ztzx0042]
  4. Chongqing medical university scientific research cultivating fund [201414]
  5. outstanding graduate student cultivation program of Chongqing Medical University [BJRC201928]

向作者/读者索取更多资源

We designed a novel luminescent metal-organic framework (MOF) named Ce-TCPP-LMOF (CTM) through a simple one-pot solvothermal method. CTM was synthesized by using the emerging electrochemiluminescent (ECL) material (4,4',4 '',4 '''-(porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid) as the organic ligand and Ce(III) as the metal node. We found that CTM not only has the remarkable ability to emit light but also has a uniform sandwich biscuit shape and suitable nanoscale size, which are promising for further applications. We also applied CTM to construct a novel ECL immunosensor and achieve sensitive detection of the proprotein convertase subtilisin/kexin type 9 (PCSK9), a biomarker related to cardiovascular diseases. To further amplify the ECL signal of CTM, a novel dual-amplified signal strategy was established by inducing a polyamidoamine dendrimer (PAMAM) and gold nanoparticles (AuNPs). Importantly, we first proved that the ECL signal of the CTM/S2O82- system could be enhanced by the PAMAM electric field. As the electron transfer rate was accelerated by the AuNP layer, this ECL signal was further enhanced in AuNP-modified electrodes. The ECL immunosensor showed desirable performance for PCSK9 analysis within a detection range of 50 fg mL(-1) to 10 ng mL(-1) and a low limit of detection of 19.12 +/- 2.69 fg mL(-1). Real sample detection suggested that the immunosensor holds great potential for analyzing clinical serum samples.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据